Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Alopecia
ADR ID BADD_A00152
ADR Hierarchy
23      Skin and subcutaneous tissue disorders
23.02      Skin appendage conditions
23.02.02      Alopecias
23.02.02.001      Alopecia
Description A disorder characterized by a decrease in density of hair compared to normal for a given individual at a given age and body location. [CTCAE] Absence of hair from areas where it is normally present. [MeSH]
MedDRA Code 10001760
MeSH ID D000505
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Accelerated hair loss | Alopecia | Alopecia reversible | Alopecia, unspecified | Atrichia | Atrichosis | Baldness | Frontal-parietal thinning | Hair loss | Hair thinning | Other alopecia | Body hair loss | Traction alopecia | Alopecia post chemotherapy | Anterolateral leg alopecia | Hair Loss | Hair Losses | Loss, Hair | Losses, Hair | Alopecia, Male Pattern | Male Pattern Alopecia | Baldness, Male Pattern | Male Pattern Baldness | Female Pattern Baldness | Baldness, Female Pattern | Androgenetic Alopecia | Pattern Baldness | Baldness, Pattern | Androgenic Alopecia | Alopecia, Androgenic | Alopecias, Androgenic | Androgenic Alopecias | Alopecia, Androgenetic | Pseudopelade | Alopecia Cicatrisata | Alopecia Cicatrisatas
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02154Tenofovir0.065529%
BADD_D02160Terbinafine0.002011%
BADD_D02161Terbinafine hydrochloride--
BADD_D02165Teriflunomide0.384141%
BADD_D02169Testolactone--
BADD_D02170Testosterone--
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate-
BADD_D02192Thalidomide--
BADD_D02195Theophylline--
BADD_D02203Thiotepa--
BADD_D02210Tiagabine--
BADD_D02211Tiagabine hydrochloride--
BADD_D02219Timolol--
BADD_D02220Timolol maleate--
BADD_D02230Tizanidine--
BADD_D02231Tizanidine hydrochloride--
BADD_D02235Tocophersolan--
BADD_D02236Tofacitinib0.183824%
BADD_D02241Tolcapone--
BADD_D02246Tolvaptan--
BADD_D02247Topiramate0.003232%
BADD_D02248Topotecan0.000627%
BADD_D02249Topotecan hydrochloride--
BADD_D02250Toremifene citrate--
BADD_D02253Trabectedin--
BADD_D02254Tramadol--
BADD_D02257Trametinib0.003817%
BADD_D02259Trandolapril--
The 22th Page    First    Pre   22 23 24 25    Next   Last    Total 25 Pages